Comparative study of ocular and generalized myasthenia gravis in a South Korean cohort
PLOS One · 28.04.2026 · 21 (4) · e0346981
DOI: 10.1371/journal.pone.0346981 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PLOS One, online erschienen am 28.04.2026. Verfasst von Chaerin Kwon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medicine, Konkuk University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Myasthenia Gravis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korea government.
Abstract (Originalsprache)
Purpose
To compare ocular myasthenia gravis (OMG) and generalized myasthenia gravis (GMG) in a South Korean cohort through an integrated analysis of clinical characteristics, diagnostic findings, and treatment patterns.
Methods
We conducted a retrospective study of 138 patients with myasthenia gravis (98 with OMG and 40 with GMG). Demographic characteristics, ophthalmic symptoms, serologic results, repetitive nerve stimulation test (RNST) findings, thymic pathology, autoimmune comorbidities, and treatment patterns were evaluated.
Results
GMG patients had a younger age at symptom onset and a higher proportion of females compared with OMG patients. Combined horizontal and vertical diplopia was more frequent in OMG. AChR antibody positivity was significantly higher in GMG than in OMG (92.5% vs. 36.3%), as were abnormal RNST findings (90.0% vs. 23.5%). A modest but statistically significant positive correlation was observed between AChR-Ab titer and the highest CMAP decrement in the overall cohort (r = 0.381, p = 0.011); however, this association was not significant when analyzed separately in OMG and GMG patients. Thymic abnormalities, particularly thymoma, were more common in GMG. Nonsteroidal immunosuppressant use—especially tacrolimus and azathioprine—was significantly more frequent in GMG, whereas corticosteroid use did not differ significantly between subtypes. Among OMG patients, systemic immunotherapy was more frequently administered to those presenting with both ptosis and diplopia than to those with isolated ptosis.
Conclusions
In this South Korean cohort, OMG and GMG exhibited distinct demographic, serologic, electrophysiologic, and therapeutic profiles. Recognition of these subtype-specific differences may facilitate accurate diagnosis, individualized treatment selection, and improved clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate School of Medicine, Konkuk University, Seoul, Republic of Korea.
- Department of Neurology, Konkuk University Medical Center, Seoul, Republic of Korea.
- Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea.
- Department of Ophthalmology, Konkuk University Medical Center, Seoul, Republic of Korea.
ORCID-Profile: Hyun Jin Shin
Förderung
- National Research Foundation of Korea (NRF) grant funded by the Korea government
Zitieren
APA
Kwon, C., Oh, J., & Shin, H. J. (2026). Comparative study of ocular and generalized myasthenia gravis in a South Korean cohort. PLOS One, 21(4), e0346981. https://doi.org/10.1371/journal.pone.0346981
Vancouver
Kwon C, Oh J, Shin HJ. Comparative study of ocular and generalized myasthenia gravis in a South Korean cohort. PLOS One. 2026;21(4):e0346981. doi:10.1371/journal.pone.0346981
BibTeX
@article{Kwon2026,
author = {Kwon, Chaerin and Oh, Jeeyoung and Shin, Hyun Jin},
title = {Comparative study of ocular and generalized myasthenia gravis in a South Korean cohort},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0346981},
doi = {10.1371/journal.pone.0346981}
}
EUVIMED